Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lymphoma 2018 NCI 5R01CA172582-05 Alpha Radioimmunotherapy for Lymphoma Treatment SANDMAIER, BRENDA FRED HUTCHINSON CANCER RESEARCH CENTER WA $634,846
Lymphoma 2018 NCI 5R01CA192267-03 Monitoring disease progression in follicular lymphoma with next-gen sequencing CARLSON, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $1
Lymphoma 2018 NCI 5R01CA196671-02 Mechanisms of Human Lymphoid Chromosomal Translocation LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $377,438
Lymphoma 2018 NIAID 5R01AI072194-09 Elucidation of Immunoglobulin Class Switch Recombination CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $439,750
Lymphoma 2018 NIAID 5R01AI105114-05 Viral Interface with an Interferon-Induced Gene REICH, NANCY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,541
Lymphoma 2018 NCI 5R01CA184187-04 DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Lymphoma 2018 NIAID 5R01AI114557-04 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $593,287
Lymphoma 2018 NCI 5P30CA014089-43 8288 Molecular Genetics Research Program (Project-001) LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $70,375
Lymphoma 2018 NIAID 5R01AI114556-04 Targeting Fnip1 to disrupt B cell development, metabolism, and transformation IRITANI, BRIAN UNIVERSITY OF WASHINGTON WA $386,250
Lymphoma 2018 NCI 5R01CA182461-05 Defining the impact of clonal evolution on chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $362,378
Lymphoma 2018 NIDCR 5R01DE025567-03 Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid ZHOU, Z UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Lymphoma 2018 NCI 5P30CA016086-42 8627 EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020) DEES, ELIZABETH UNIV OF NORTH CAROLINA CHAPEL HILL NC $287,365
Lymphoma 2018 NIGMS 5R01GM111741-04 High-throughput informatics for antibodies MACCARTHY, THOMAS STATE UNIVERSITY NEW YORK STONY BROOK NY $266,488
Lymphoma 2018 NCI 5R01CA158073-07 The Role of ATM in Suppression of Lymphomas ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $380,000
Lymphoma 2018 NCI 5R01CA203923-02 IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis TARAKANOVA, VERA MEDICAL COLLEGE OF WISCONSIN WI $352,275
Lymphoma 2018 NCI 5R01CA149707-07 Investigating the functions of the miR-17~92 family of oncogenic microRNA clusters VENTURA, ANDREA SLOAN-KETTERING INST CAN RESEARCH NY $385,650
Lymphoma 2018 NCI 5R01CA183444-05 Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $501,285
Lymphoma 2018 NCI 5R01CA201135-02 Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma JAMES, RICHARD SEATTLE CHILDREN'S HOSPITAL WA $427,373
Lymphoma 2018 NCI 5R00CA183914-05 A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment WAN, LIXIN H. LEE MOFFITT CANCER CTR & RES INST FL $148,607
Lymphoma 2018 NCI 5R01CA172724-04 Novel Strategies to Target Leukemia-Stromal Interactions PELICANO, HELENE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Lymphoma 2018 NIAID 5R01AI108407-04 Role of MHV68 miRNAs in latencyand pathogenesis TIBBETTS, SCOTT UNIVERSITY OF FLORIDA FL $417,433
Lymphoma 2018 NCI 5R01CA157644-09 Targeted activation of autoimmune checkpoints in B cell malignancies MUSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $410,875
Lymphoma 2018 NCI 5P30CA006516-53 5400 Program 6: Lymphoma and Myeloma SHIPP, MARGARET DANA-FARBER CANCER INST MA $73,653
Lymphoma 2018 NIGMS 5R00GM112877-03 Understanding Epstein Barr virus oncogenicity through non-coding RNA structure MOSS, WALTER IOWA STATE UNIVERSITY IA $249,000
Lymphoma 2018 NIAID 5R21AI128598-03 Role of Siglec-10/G as a tumor suppressor in B-cells MACAULEY, MATTHEW UNIVERSITY OF ALBERTA CANADA $108,000
Lymphoma 2018 NCI 5P30CA008748-52 7551 Monoclonal Antibody WEIS-GARCIA, FRANCES SLOAN-KETTERING INST CAN RESEARCH NY $282,758
Lymphoma 2018 NCI 5R01CA196266-03 A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $860,660
Lymphoma 2018 NCI 5R01CA194263-03 Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders FANG, CAROLYN RESEARCH INST OF FOX CHASE CAN CTR PA $632,188
Lymphoma 2018 NIAID 5F30AI131496-02 Dissecting the role of HVEM and BTLA in constraining the germinal center B cell response MINTZ, MICHELLE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $36,478
Lymphoma 2018 NIAID 5R37AI037526-24 Class Switch Recombination in B Lymphocytes NUSSENZWEIG, MICHEL ROCKEFELLER UNIVERSITY NY $847,500
Lymphoma 2018 NCI 5F31CA213668-02 CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells KUHN, NICHOLAS SLOAN-KETTERING INST CAN RESEARCH NY $44,524
Lymphoma 2018 NIAID 5R01AI124186-03 RNA-directed targeting of AID in immunity and genomic integrity CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $428,500
Lymphoma 2018 NIDCR 5R01DE025208-04 KSHV latent infection replication KAYE, KENNETH BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2018 NCI 1R21CA221683-01 Development of molecular probes to investigate and drug the oncogenic Wnt/?-catenin/BCL9/B9L transcriptional complex CARRASCO, RUBEN DANA-FARBER CANCER INST MA $229,576
Lymphoma 2018 NIAID 5R01AI106676-05 Epstein Barr virus antisense transcription FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $376,250
Lymphoma 2018 NCI 5R01CA193140-03 Targeting the Ig-light chains with CAR-T cells in lymphoid tumors DOTTI, GIANPIETRO UNIV OF NORTH CAROLINA CHAPEL HILL NC $511,190
Lymphoma 2018 NIGMS 1P20GM121316-01A1 8789 Role of E3 Ligase, UBR5, in Hematopoietic Differentiation and Lymphomagenesis BUCKLEY, SHANNON UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $278,465
Lymphoma 2018 NCI 5R01CA180758-06 KSHV interactions with host inflammasome components CHANDRAN, BALA UNIVERSITY OF SOUTH FLORIDA FL $301,889
Lymphoma 2018 NCI 5F31CA192835-04 Intratumoral Heterogeneity and Tumor Evolution in Lymphoma KASTENHUBER, EDWARD SLOAN-KETTERING INST CAN RESEARCH NY $26,208
Lymphoma 2018 NCI 2P50CA107399-11A1 5657 Core A: Administrative Core FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $63,967
Lymphoma 2018 NCI 2P50CA107399-11A1 5658 Biostatistics and Research Informatics Core PALMER, JOYCELYNNE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $171,775
Lymphoma 2018 NCI 2P50CA107399-11A1 5659 Biospecimen Bank CHAN, WING BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $174,611
Lymphoma 2018 NCI 2P50CA107399-11A1 5660 GMP Manufacturing KWAK, LARRY BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $313,709
Lymphoma 2018 NCI 2P50CA107399-11A1 5661 CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $281,345
Lymphoma 2018 NCI 2P50CA107399-11A1 5662 Therapy-related leukemia following autologous transplantation for lymphoma BHATIA, SMITA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $676,409
Lymphoma 2018 NCI 2P50CA107399-11A1 5663 Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma CHEN, ROBERT BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $336,786
Lymphoma 2018 NCI 2P50CA107399-11A1 5664 Novel nucleotide-based approaches targeting the STAT3 pathway for the treatment of lymphoma YU, HUA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $312,478
Lymphoma 2018 NCI 2P50CA107399-11A1 5665 Developmental Research Program KWAK, LARRY BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $84,460
Lymphoma 2018 NCI 2P50CA107399-11A1 5666 Career Enhancement Program FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $84,460
Lymphoma 2018 NIEHS 5U13ES026496-03 Childhood Leukemia International Consortium Scientific Annual Meetings METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $15,000
Lymphoma 2018 NIGMS 5R01GM073857-11 Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides ENGELMAN, DONALD YALE UNIVERSITY CT $569,403
Lymphoma 2018 NCI 5R01CA190384-04 The genomic pathogenesis of Follicular Lymphoma MALEK, SAMI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $520,601
Lymphoma 2018 NCI 1R01CA223232-01 Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma RAMOS, JUAN CARLOS UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $369,155
Lymphoma 2018 NIAID 1R03AI135154-01 Cytometric Enumeration of EBV-Infected Cells STOWE, RAYMOND MICROGEN, LLC TX $78,500
Lymphoma 2018 NCI 5R01CA214046-02 Targeted Therapies for Richters Transformation LAPALOMBELLA, ROSA OHIO STATE UNIVERSITY OH $461,935
Lymphoma 2018 NIAID 5R01AI110328-05 Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection SAMPLE, JEFFERY PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $377,956
Lymphoma 2018 NCI 5P01CA214091-02 6349 "Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression RENNE, ROLF UNIVERSITY OF FLORIDA FL $288,290
Lymphoma 2018 NCI 5P01CA214091-02 6350 "Project 2" Epstein-Barr virus LMP2 IncRNAs FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $289,846
Lymphoma 2018 NCI 5P01CA214091-02 6351 "Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis TIBBETTS, SCOTT UNIVERSITY OF FLORIDA FL $307,212
Lymphoma 2018 NCI 5P01CA214091-02 6353 "Core B" Virus RNA-seq and Bioinformatics Core FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $214,241
Lymphoma 2018 NIDCR 5R01DE026003-03 Targeting an immune kinase to purge KSHV latent infection FENG, PINGHUI UNIVERSITY OF SOUTHERN CALIFORNIA CA $676,564
Lymphoma 2018 NIDCR 5R01DE025985-03 KSHV Replication in Oral Epithelial Cells IZUMIYA, YOSHIHIRO UNIVERSITY OF CALIFORNIA AT DAVIS CA $392,500
Lymphoma 2018 NIDCR 5R01DE025994-03 Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells LUFTIG, MICAH DUKE UNIVERSITY NC $437,944
Lymphoma 2018 NCI 1R21CA216660-01A1 Clonal Expansion of HTLV-1-Infected Cells and Adult T Cell Leukemia GIAM, CHOU-ZEN HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $205,591
Lymphoma 2018 NCI 5R35CA200422-03 Molecular Basis of KSHV oncogenesis JUNG, JAE UNIVERSITY OF SOUTHERN CALIFORNIA CA $943,324
Lymphoma 2018 NCI 5R01CA076167-15 Genetic Analysis of Myeloproliferative Disease COWELL, JOHN AUGUSTA UNIVERSITY GA $307,800
Lymphoma 2018 NCI 5F30CA189433-05 Investigating the function of MTBP in lymphoma PUCCETTI, MATTHEW THOMAS JEFFERSON UNIVERSITY PA $49,524
Lymphoma 2018 NCI 5R01CA137488-23 Two Compartment Models to Improve Brain Tumor Therapy NEUWELT, EDWARD OREGON HEALTH & SCIENCE UNIVERSITY OR $447,921
Lymphoma 2018 NCI 5R01CA180813-05 Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs GOTTWEIN, EVA NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Lymphoma 2018 NCI 5R01CA184384-05 Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging FELSHER, DEAN STANFORD UNIVERSITY CA $528,101
Lymphoma 2018 NIDCR 5R00DE024969-04 Factors Influencing KSHV Infection and Spread within the Oral Cavity TOTONCHY, JENNIFER CHAPMAN UNIVERSITY CA $249,000
Lymphoma 2018 NIAID 5R01AI123420-03 Targeting Epstein-Barr Virus super-enhancers ZHAO, BO BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2018 NCI 5R01CA179363-05 Molecular signature of inflammation MALARKANNAN, SUBRAMANIAM MEDICAL COLLEGE OF WISCONSIN WI $321,301
Lymphoma 2018 NCI 5R01CA151898-08 CRLF2 signaling in B-cell acute lymphoblastic leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $392,969
Lymphoma 2018 NCI 5R01CA075922-22 Rhesus HHV-8 homologue in AIDS-related malignancies WONG, SCOTT OREGON HEALTH & SCIENCE UNIVERSITY OR $727,306
Lymphoma 2018 NCI 5R33CA212968-02 LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics SINGH, ANKUR CORNELL UNIVERSITY NY $372,315
Lymphoma 2018 NCI 5F30CA183263-04 Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics KERN, HANNA UNIVERSITY OF WASHINGTON WA $38,575
Lymphoma 2018 NCI 5R01CA204621-03 Modulation of Host Cell Exosome Content and Function by EBV LMP1 MECKES, DAVID FLORIDA STATE UNIVERSITY FL $340,938
Lymphoma 2018 NCI 5F30CA206343-03 The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas COONEY, JEFFREY UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $40,028
Lymphoma 2018 NCI 7R01CA211963-02 Ionizing radiation induced hematological malignancies ZHOU, DAOHONG UNIVERSITY OF FLORIDA FL $368,866
Lymphoma 2018 NCI 2R01CA176647-06 Mutant p53 as actionable cancer-specific target MOLL, UTE STATE UNIVERSITY NEW YORK STONY BROOK NY $382,587
Lymphoma 2018 NCI 1R33CA223908-01 Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform KONRY, TANIA NORTHEASTERN UNIVERSITY MA $421,501
Lymphoma 2018 NIDCR 5R01DE025804-03 Role of IKK epsilon in KSHV/HHV8 associated malignancies CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Lymphoma 2018 NCI 5P01CA174653-05 6845 Pathology BHAGAT, GOVIND COLUMBIA UNIVERSITY NY $188,902
Lymphoma 2018 NCI 5P01CA174653-05 6841 The Role of CTIP in Lymphocyte Development and Lymphomagenesis ZHA, SHAN COLUMBIA UNIVERSITY NY $364,328
Lymphoma 2018 NCI 1R01CA207196-01A1 New mechanisms for modulating the MALT1 oncoprotein MCALLISTER-LUCAS, LINDA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $536,920
Lymphoma 2018 NCI 2R01CA117830-11A1 Epigenomic Control of KSHV Latency LIEBERMAN, PAUL WISTAR INSTITUTE PA $361,000
Lymphoma 2018 NCI 1R01CA207963-01A1 Role of FOXO1 mutations in the pathogenesis of B cell non-Hodgkin lymphomas DOMINGUEZ-SOLA, DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $385,431
Lymphoma 2018 NCI 5R01CA179062-04 Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy SOTOMAYOR, EDUARDO GEORGE WASHINGTON UNIVERSITY DC $362,569
Lymphoma 2018 NCI 5R01CA142698-09 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $409,002
Lymphoma 2018 NCI 5R01CA187415-04 MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma LI, YONG CLEVELAND CLINIC LERNER COM-CWRU OH $457,439
Lymphoma 2018 OD 1R21OD023822-01A1 A New Method for Mosaic Analysis of Clonal Mutations in Mice ZHUANG, YUAN DUKE UNIVERSITY NC $199,479
Lymphoma 2018 NCI 5R01CA184728-05 Targeting Granzyme B to Separate GVH from GVL Responses CAO, XUEFANG UNIVERSITY OF MARYLAND BALTIMORE MD $353,419
Lymphoma 2018 NCI 5R01CA192928-04 Dual targeting of XPO1 and BTK in B cell malignancies LAPALOMBELLA, ROSA OHIO STATE UNIVERSITY OH $512,016
Lymphoma 2018 NCI 1R01CA224304-01 Self-assembled multifunctional aptamer-complex biomaterial for precision medicine ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE TX $369,431
Lymphoma 2018 NCI 5UH2CA206127-02 Molecular diagnostic and prognostic signatures for PTCL IQBAL, JAVEED UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $191,615
Lymphoma 2018 NIAID 1U01AI135947-01 The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $635,667
Lymphoma 2018 NCI 5R01CA186935-04 Regulation of gamma delta T cell immunoediting by novel phosphoantigens WIEMER, ANDREW UNIVERSITY OF CONNECTICUT STORRS CT $371,265
Lymphoma 2018 NCI 5F31CA213871-02 Investigating the Role of Transcription on DNA Damage at Early Replicating Fragile Sites ST GERMAIN, COMMODORE UNIVERSITY OF CALIFORNIA AT DAVIS CA $36,466
Lymphoma 2018 NCI 5R01CA210250-02 BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $390,134
Lymphoma 2018 NCI 1R01CA215518-01A1 Targeting the Notch:Myc axis in leukemia/lymphoma PEAR, WARREN UNIVERSITY OF PENNSYLVANIA PA $468,293
Lymphoma 2018 NCI 5R01CA208352-02 Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma WANG, XINJIANG ROSWELL PARK CANCER INSTITUTE CORP NY $373,760
Lymphoma 2018 NINDS 1R35NS105109-01 Molecular Mechanisms of Drug Resistance in Primary Brain Tumors MELLINGHOFF, INGO SLOAN-KETTERING INST CAN RESEARCH NY $601,125
Lymphoma 2018 NIAID 5R01AI121300-03 Non-coding RNAs in Gammaherpesvirus Infection and Disease VAN DYK, LINDA UNIVERSITY OF COLORADO DENVER CO $385,420
Lymphoma 2018 NCI 5K99CA215307-02 Glycine metabolism in cancer DUCKER, GREGORY PRINCETON UNIVERSITY NJ $99,004
Lymphoma 2018 NCI 5R01CA193655-04 Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $510,478
Lymphoma 2018 NCI 5P30CA086862-18 7673 Program 4: Cancer Epidemiology and Population Science LYNCH, CHARLES UNIVERSITY OF IOWA IA $30,038
Lymphoma 2018 NCI 5R01CA203721-03 Transforming the diagnosis and care of patients with CTCL using TCR sequencing CLARK, RACHAEL BRIGHAM AND WOMEN'S HOSPITAL MA $679,022
Lymphoma 2018 NCI 5F32CA203217-03 Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis FERNANDEZ, MARIO H. LEE MOFFITT CANCER CTR & RES INST FL $65,158
Lymphoma 2018 NIGMS 5SC1GM122648-02 Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma MALLIKARATCHY, PRABODHIKA HERBERT H. LEHMAN COLLEGE NY $371,250
Lymphoma 2018 NCI 5F30CA196082-04 Defining the role of mutant XPO1 in chronic lymphocytic leukemia HING, ZACHARY OHIO STATE UNIVERSITY OH $49,524
Lymphoma 2018 NIAID 1R41AI136225-01 Numeric Expansion of CD-19 Specific T cells in Magnetic 3D Culture TSENG, HUBERT NANO3D BIOSCIENCES, INC. TX $175,849
Lymphoma 2018 NCI 1F30CA225052-01 The role of a novel fusion oncogene FYN-TRAF3IP2 in peripheral T-cell lymphoma KIM, CHRISTINE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $41,983
Lymphoma 2018 NCI 2R13CA124293-11 Annual International Primary CNS Lymphoma Collaborative Group Meeting BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL MA $5,000
Lymphoma 2018 NIAID 5R01AI109644-05 Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di SUN, ZUOMING BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $420,000
Lymphoma 2018 NCI 1R01CA225029-01 Mechanisms of Obesity-Induced Genetic Instability at Endogenous Mutation Hotspots VASQUEZ, KAREN UNIVERSITY OF TEXAS, AUSTIN TX $459,365
Lymphoma 2018 NCI 1UG3CA225021-01 Methods and Tools for Integrating Pathomics Data into Cancer Registries SALTZ, JOEL STATE UNIVERSITY NEW YORK STONY BROOK NY $430,543
Lymphoma 2018 NCI 5R01CA193541-04 Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia KAY, NEIL MAYO CLINIC ROCHESTER MN $691,685
Lymphoma 2018 NCI 5R01CA155010-08 Personal tumor neoantigens for immunity against chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $675,300
Lymphoma 2018 NCI 5P01CA174439-06 Early Events in KSVH Infection of Primary B-cells ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $1,110,758
Lymphoma 2018 NCI 5R01CA183876-05 Towards The Chemotherapy-Free Treatment of Follicular Lymphoma WENDEL, HANS-GUIDO SLOAN-KETTERING INST CAN RESEARCH NY $475,801
Lymphoma 2018 NCI 5R01CA188286-04 SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $348,844
Lymphoma 2018 NCI 5R21CA205106-02 A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies OGEMBO, JAVIER BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $176,605
Lymphoma 2018 NCI 5R01CA206019-03 Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $802,716
Lymphoma 2018 NCI 5R01CA188561-05 The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia OPAVSKY, RENE UNIVERSITY OF FLORIDA FL $348,844
Lymphoma 2018 NCI 5P30CA023100-32 6336 Hematologic Malignancies LIPPMAN, SCOTT UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $22,398
Lymphoma 2018 NCI 5P01CA125066-10 7158 Isolation Chemistry of Tropical Plants and Biological Evaluation KINGHORN, ALAN OHIO STATE UNIVERSITY OH $252,341
Lymphoma 2018 NCI 5P01CA087497-17 5245 Core C - The Molecular Systems Pathology Core CORDON-CARDO, CARLOS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $247,698
Lymphoma 2018 NIGMS 1R35GM126902-01 Control Mechanisms of Human Voltage Gated Proton Channels, hHv1 DECOURSEY, THOMAS RUSH UNIVERSITY MEDICAL CENTER IL $317,598
Lymphoma 2018 NCI 5R01CA216273-02 (PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $740,321
Lymphoma 2018 NIAID 5R01AI113130-03 New Therapeutics for Post-Transplant Lymphoproliferative Disorder MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $398,138
Lymphoma 2018 NCI 5R44CA183316-03 A Phase I trial combining IV fenretinide and IV safingol to target overproduction SIMPSON, WILLIAM CERRX, INC. TX $473,425
Lymphoma 2018 NCI 5R01CA073507-20 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $372,677
Lymphoma 2018 NCI 5R01CA076445-17 Studies of HHV-8 vIL-6 Function NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $384,750
Lymphoma 2018 NCI 5R01CA200703-03 Genetic Epidemiology of non-Hodgkin Lymphoma CERHAN, JAMES MAYO CLINIC ROCHESTER MN $660,329
Lymphoma 2018 NCI 5R01CA206404-03 Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques. WONG, SCOTT OREGON HEALTH & SCIENCE UNIVERSITY OR $1,263,878
Lymphoma 2018 NIGMS 5R35GM118009-03 Site-Specific Recombination in Human Health & Disease LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $487,031
Lymphoma 2018 NCI 5R01CA181319-05 Targeting Stem-Cell Dependent Drug Resistance in Human MCL MCCARTY, NAMI UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $313,723
Lymphoma 2018 NCI 5R01CA186775-05 Development of a Small Molecule Inhibitor for KSHV LANA LIEBERMAN, PAUL WISTAR INSTITUTE PA $394,250
Lymphoma 2018 NCI 5R01CA206476-03 (PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection CHIAO, ELIZABETH BAYLOR COLLEGE OF MEDICINE TX $706,386
Lymphoma 2018 NCI 5R01CA194547-04 The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma ELEMENTO, OLIVIER WEILL MEDICAL COLL OF CORNELL UNIV NY $530,098
Lymphoma 2018 NCI 5R01CA181699-05 Investigating the roles of lncRNAs in cancer and development VENTURA, ANDREA SLOAN-KETTERING INST CAN RESEARCH NY $419,643
Lymphoma 2018 NCI 5R01CA187299-04 Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma RUI, LIXIN UNIVERSITY OF WISCONSIN-MADISON WI $349,988
Lymphoma 2018 NCI 5U01CA194389-04 Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma ALIZADEH, ARASH STANFORD UNIVERSITY CA $632,932
Lymphoma 2018 NCI 5U01CA195568-04 The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study CERHAN, JAMES MAYO CLINIC ROCHESTER MN $2,246,690
Lymphoma 2018 NCI 5R01CA182947-05 Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells FARAG, SHERIF INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $319,738
Lymphoma 2018 NCI 2P30CA043703-28 8084 Hematopoietic and Immune Cancer Biology Research Program MACIEJEWSKI, JAROSLAW CASE WESTERN RESERVE UNIVERSITY OH $76,190
Lymphoma 2018 NCI 2P01CA022443-41 8185 Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN-MADISON WI $386,771
Lymphoma 2018 NCI 2P01CA022443-41 8186 Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $392,814
Lymphoma 2018 NCI 2P01CA022443-41 8187 Project 5 - EBV Drivers of Oncogenesis and Novel Therapies KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $393,288
Lymphoma 2018 NCI 5R01CA189806-05 Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma MOORMANN, ANN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $501,464
Lymphoma 2018 NCI 5R01CA182905-05 Protein-coding and non-coding RNA biomarkers for early detection of CLL CALIN, GEORGE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $534,489
Lymphoma 2018 NCI 5F30CA203292-04 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK NORTHWESTERN UNIVERSITY AT CHICAGO IL $49,524
Lymphoma 2018 NCI 1P01CA214274-01A1 5029 Project 1: Therapeutic targeting of CDK4 in Mantle Cell Lymphoma CHEN-KIANG, SELINA WEILL MEDICAL COLL OF CORNELL UNIV NY $377,925
Lymphoma 2018 NCI 1P01CA214274-01A1 5030 Project 2: Role of FOXO and Chromatin Remodeling in Cell Cycle Therapy for MCL PAIK, JIHYE WEILL MEDICAL COLL OF CORNELL UNIV NY $216,633
Lymphoma 2018 NCI 1P01CA214274-01A1 5031 Project 3: Targeting PRMT5 in Mantle Cell Lymphoma BAIOCCHI, ROBERT OHIO STATE UNIVERSITY OH $288,007
Lymphoma 2018 NCI 1P01CA214274-01A1 5032 Core A: Administrative Core CHEN-KIANG, SELINA WEILL MEDICAL COLL OF CORNELL UNIV NY $202,373
Lymphoma 2018 NCI 1P01CA214274-01A1 5033 Core B: Pathology Core ELY, SCOTT WEILL MEDICAL COLL OF CORNELL UNIV NY $230,479
Lymphoma 2018 NCI 1P01CA214274-01A1 5034 Core C: Genomics & Bioinformatics Core ELEMENTO, OLIVIER WEILL MEDICAL COLL OF CORNELL UNIV NY $393,916
Lymphoma 2018 NCI 1P01CA214274-01A1 5035 Core D: Biostatistics Core BALLMAN, KARLA WEILL MEDICAL COLL OF CORNELL UNIV NY $94,571
Lymphoma 2018 NCI 2P30CA033572-35 5263 Hematologic Malignancies FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $42,489
Lymphoma 2018 NCI 5P30CA124435-11 7150 Lymphoma & Leukemia Research Program (Project-007) LEVY, RONALD STANFORD UNIVERSITY CA $43,896
Lymphoma 2018 NCI 5R01CA213138-02 CD25-mediated feedback control of BCR-signaling and its oncogenic mimics MÜSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $395,738
Lymphoma 2018 NCI 5K99CA212302-02 Resistance To Targeted Immunotherapies:CART19 as a Paradigm RUELLA, MARCO UNIVERSITY OF PENNSYLVANIA PA $174,096
Lymphoma 2018 NIAID 1R01AI137267-01 Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $735,750
Lymphoma 2018 NIAID 1R01AI137337-01 Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis GEWURZ, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $447,500
Lymphoma 2018 NIAID 5R21AI133050-02 Analysis of Mbd4 function during the generation of Ig diversity KENTER, AMY UNIVERSITY OF ILLINOIS AT CHICAGO IL $199,875
Lymphoma 2018 NCI 5R01CA214890-02 Vitamin D and Follicular Lymphoma FRIEDBERG, JONATHAN UNIVERSITY OF ROCHESTER NY $615,082
Lymphoma 2018 NIAID 1K23AI137183-01 Role of B cell activating factor in non-infectious complications of common variable immunodeficiency MAGLIONE, PAUL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $190,299
Lymphoma 2018 NCI 1K08CA226352-01 Targeting transducin Beta-like protein 1 in mantle cell lymphoma ALINARI, LAPO OHIO STATE UNIVERSITY OH $227,046
Lymphoma 2018 NCI 1U01CA220401-01A1 Informatics Tools for Quantitative Digital Pathology Profiling and Integrated Prognostic Modeling COOPER, LEE EMORY UNIVERSITY GA $467,872
Lymphoma 2018 NCI 5R21CA220475-02 PDL1 expression on B cells: a potential marker of pre-tumor cells in AIDS-NHL EPELDEGUI, MARTA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $169,650
Lymphoma 2018 NIDDK 5K08DK100739-05 The Intraepithelial T cell Response in Celiac Disease HAN, ARNOLD COLUMBIA UNIVERSITY HEALTH SCIENCES NY $166,212
Lymphoma 2018 NIAID 5R01AI127642-02 Targeting of somatic hypermutation in the genome SCHATZ, DAVID YALE UNIVERSITY CT $418,750
Lymphoma 2018 NCI 5R01CA161026-08 Targetable Immune Evasion Pathways in Hodgkin Lymphoma SHIPP, MARGARET DANA-FARBER CANCER INST MA $373,399
Lymphoma 2018 NCI 5P01CA016038-44 7371 Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA MILLER, I. YALE UNIVERSITY CT $197,935
Lymphoma 2018 NCI 5P01CA016038-44 7373 Project 3, Steitz: Viral Noncoding RNAs and Cell Transformation STEITZ, JOAN YALE UNIVERSITY CT $123,787
Lymphoma 2018 NCI 5P01CA019014-39 7901 Project 2 - Membrane trafficking in EBV malignancies: Implication of deubiquitinase UCH-L1 PAGANO, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $287,949
Lymphoma 2018 NCI 5P01CA019014-39 7902 Project 3 - Modulation of host cell biology by KSHV DAMANIA, BLOSSOM UNIV OF NORTH CAROLINA CHAPEL HILL NC $280,088
Lymphoma 2018 NCI 5P01CA019014-39 7903 Project 4 - Study of KSHV Carcinogenesis DITTMER, DIRK UNIV OF NORTH CAROLINA CHAPEL HILL NC $281,393
Lymphoma 2018 NCI 5K24CA184039-05 Molecularly Targeted Therapy for Lymphoma GOPAL, AJAY UNIVERSITY OF WASHINGTON WA $171,401
Lymphoma 2018 NCI 5K23CA184279-05 Molecular determinants of prognosis in limited-stage follicular lymphoma LOUISSAINT, ABNER MASSACHUSETTS GENERAL HOSPITAL MA $140,263
Lymphoma 2018 NCI 5R01CA206462-03 SIRT2 Inhibitors for the Treatment of B-cell Lymphoma SIMON, JULIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $574,754
Lymphoma 2018 NCI 5K08CA191019-05 The Role of ZEB1 Mutations in Cutaneous T Cell Lymphoma CHOI, JAEHYUK NORTHWESTERN UNIVERSITY AT CHICAGO IL $152,172
Lymphoma 2018 NCI 5R01CA095318-14 Role of B cells in murine gammaherpesvirus 68 SPECK, SAMUEL EMORY UNIVERSITY GA $368,305
Lymphoma 2018 NCI 5R01CA140337-08 Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation LUFTIG, MICAH DUKE UNIVERSITY NC $371,732
Lymphoma 2018 NCI 5R01CA187799-04 Role of FOXP1 and WNT signaling in B-cell Lymphoma MAJOR, MICHAEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $307,500
Lymphoma 2018 NCI 5R01CA196703-04 Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma CHIARLE, ROBERTO BOSTON CHILDREN'S HOSPITAL MA $404,888
Lymphoma 2018 NCI 5R01CA214131-02 Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1 CHOI, YOUNG BONG JOHNS HOPKINS UNIVERSITY MD $374,578
Lymphoma 2018 NCI 5K24CA208132-03 Mentored Patient Oriented Research in Lymphoma FLOWERS, CHRISTOPHER EMORY UNIVERSITY GA $164,375
Lymphoma 2018 NCI 5R01CA201309-03 How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia NICOT, CHRISTOPHE UNIVERSITY OF KANSAS MEDICAL CENTER KS $347,112
Lymphoma 2018 NIDCR 5R01DE024971-04 Platform technology for detection of cancer-associated viruses in HIV patients DEMIRCI, UTKAN STANFORD UNIVERSITY CA $423,475
Lymphoma 2018 NCI 5P30CA091842-17 6313 Hematopoietic Development and Malignancy (Project-002) EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY MO $62,182
Lymphoma 2018 NCI 5R01CA201380-03 Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation GREEN, MICHAEL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $340,445
Lymphoma 2018 NCI 5R01CA212162-02 Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma NOVAK, ANNE MAYO CLINIC ROCHESTER MN $650,403
Lymphoma 2018 NCI 5R01CA187040-06 Targeting SIRT1 in Mantle Cell Lymphoma SETO, EDWARD GEORGE WASHINGTON UNIVERSITY DC $274,620
Lymphoma 2018 NCI 5P01CA190193-04 8720 Project 1: Direct & Repeated pO2 Measurements for Cancer using EPR with Carbon Pa KUPPUSAMY, PERIANNAN DARTMOUTH COLLEGE NH $476,425
Lymphoma 2018 NCI 5R01CA114536-13 TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS RIDDELL, STANLEY FRED HUTCHINSON CANCER RESEARCH CENTER WA $458,731
Lymphoma 2018 NHLBI 5R01HL130539-03 STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines NEILAN, TOMAS MASSACHUSETTS GENERAL HOSPITAL MA $628,461
Lymphoma 2018 NCI 5F31CA217004-02 Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas HARRINGTON, COLLEEN UNIVERSITY OF PENNSYLVANIA PA $44,524
Lymphoma 2018 NCI 5F30CA210539-03 Epigenetic activity of normal and cancer-associated mutant H1 linker histones HEALTON, SEAN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $44,524
Lymphoma 2018 NCI 5F31CA210429-03 WDR5 as a Critical Co-Factor for MYC FOSHAGE, AUDRA VANDERBILT UNIVERSITY TN $29,196
Lymphoma 2018 NCI 1R03CA227343-01 Refined genetic models of oncogenic Myc/Igh translocations in mature B cells DOMINGUEZ-SOLA, DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $84,750
Lymphoma 2018 NCI 5R01CA204258-02 Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors NICHOLS, HAZEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $626,296
Lymphoma 2018 NCI 5P30CA013696-44 6105 Lymphoid Development and Malignancy Program EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $36,802
Lymphoma 2018 NCI 5R44CA210841-03 Precision quality check of immunotherapeutics via single-cell cytokine mapping ZHOU, JING ISOPLEXIS, INC. DE $910,459
Lymphoma 2018 NCI 5P30CA006973-55 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $55,373
Lymphoma 2018 NCI 5R01CA197870-04 Improving BTK Directed Therapy for CLL WOYACH, JENNIFER OHIO STATE UNIVERSITY OH $352,275
Lymphoma 2018 NCI 5F30CA189740-05 Alternative End-Joining in DNA Repair and Chromosomal Translocations KUMAR, VIPUL HARVARD MEDICAL SCHOOL MA $49,524
Lymphoma 2018 NCI 5R03CA219760-02 Grail-targeting breaks the immune tolerance to melanoma NURIEVA, ROZA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Lymphoma 2018 NCI 5F31CA220854-02 Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL) ROSENBERG, ERIC YALE UNIVERSITY CT $29,235
Lymphoma 2018 NLM 5R21LM012395-02 Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations EDWARDS, JOHN WASHINGTON UNIVERSITY MO $193,265
Lymphoma 2018 NCI 5K08CA219473-02 Rational Translation of EZH2 Targeted Therapy in Germinal Center B-cell Lymphoma ROTH, LISA WEILL MEDICAL COLL OF CORNELL UNIV NY $170,914
Lymphoma 2018 NCI 5F31CA221012-02 Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma ANDREWS, JARED WASHINGTON UNIVERSITY MO $30,434
Lymphoma 2018 NCI 2R01CA164605-06 Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $401,319
Lymphoma 2018 NCI 2R01CA174844-04 A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia RADER, CHRISTOPH SCRIPPS FLORIDA FL $575,010
Lymphoma 2018 NCI 1R01CA219957-01A1 Chromatin remodeling and FOXO in targeting CDK4 in mantle cell lymphoma CHEN-KIANG, SELINA WEILL MEDICAL COLL OF CORNELL UNIV NY $387,731
Lymphoma 2018 NIAID 1R01AI132731-01A1 Cell decision underlying B-cell immune responses HOFFMANN, ALEXANDER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $462,560
Lymphoma 2018 NCI 5R01CA207513-03 Role of KLHL6 inactivation in mature B-cell malignancies BUSINO, LUCA UNIVERSITY OF PENNSYLVANIA PA $368,288
Lymphoma 2018 NCI 5F30CA221250-02 A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles SCHNORENBERG, MATHEW UNIVERSITY OF CHICAGO IL $49,524
Lymphoma 2018 NCI 5F30CA210518-03 Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML DENG, LISA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $49,524
Lymphoma 2018 NCI 5R01CA163217-08 Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma DITTMER, DIRK UNIV OF NORTH CAROLINA CHAPEL HILL NC $342,759
Lymphoma 2018 NCI 5R01CA139083-10 Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages RUBENSTEIN, JAMES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $370,554
Lymphoma 2018 NCI 5K08CA190855-05 Enhancing anti-tumor immune responses in colon cancer metastases MAKER, AJAY UNIVERSITY OF ILLINOIS AT CHICAGO IL $181,818
Lymphoma 2018 NCI 5R01CA188794-05 Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma CHEN-KIANG, SELINA WEILL MEDICAL COLL OF CORNELL UNIV NY $351,713
Lymphoma 2018 NCI 1K08CA207882-01A1 Immune Targeting of non-Hodgkin Lymphoma through Integrative Antigen Presentation Profiling KHODADOUST, MICHAEL STANFORD UNIVERSITY CA $173,532
Lymphoma 2018 NCI 5R01CA202712-03 Risk factors for molecular subtypes of NHL a prospective evaluation WANG, SOPHIA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $668,277
Lymphoma 2018 NEI 5K01ES025431-06 The role of epigenetic heterogeneity in CLL evolution LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV NY $187,920
Lymphoma 2018 NCI 5R35CA210105-03 From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $960,000
Lymphoma 2018 NIAAA 5R01AA024770-03 A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers. FERRARI, PIETRO INTERNATIONAL AGENCY FOR RES ON CANCER FR $417,778
Lymphoma 2018 NCI 5R00CA175181-05 The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis SKALSKY, REBECCA OREGON HEALTH & SCIENCE UNIVERSITY OR $219,120
Lymphoma 2018 NCI 5R01CA076287-19 Pretargeted Radioimmunotherapy of CD20+ Lymphomas GREEN, DAMIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $379,044
Lymphoma 2018 NIGMS 5R01GM095606-08 Drug-Free Macromolecular Therapeutics KOPECEK, JINDRICH UNIVERSITY OF UTAH UT $298,000
Lymphoma 2018 NCI 5R21CA220147-02 Single-cell analysis of tumor-microenvironment interactions in follicular lymphoma KHARCHENKO, PETER HARVARD MEDICAL SCHOOL MA $136,832
Lymphoma 2018 NCI 5K23CA212271-03 Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies STEPHENS, DEBORAH UNIVERSITY OF UTAH UT $180,360
Lymphoma 2018 NCI 5R00CA187192-04 Ultrasensitive Quantitation of Circulating Tumor DNA NEWMAN, AARON STANFORD UNIVERSITY CA $249,000
Lymphoma 2018 NCI 5UH2CA217847-02 Development of Mantle Cell Lymphoma Proliferation Signature Assay RIMSZA, LISA MAYO CLINIC ARIZONA AZ $198,578
Lymphoma 2018 NHLBI 5UG1HL069315-18 MSKCC BMT CTN Renewal PERALES, MIGUEL-ANGEL SLOAN-KETTERING INST CAN RESEARCH NY $192,604
Lymphoma 2018 NHLBI 5UG1HL108945-08 Targeting HIV and EBV Antigens in Patients with HIV Lymphoma HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $185,957
Lymphoma 2018 NLM 5R21LM012618-02 Bayesian Generative Methods for Extracting and Modeling Relations in EHR Narratives LUO, YUAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $181,755
Lymphoma 2018 NCI 5P30CA016520-42 4005 Melanoma and Cutaneous Malignancies Research Program SCHUCHTER, LYNN UNIVERSITY OF PENNSYLVANIA PA $155,631
Lymphoma 2018 NCI 5P30CA016520-42 8007 Hematologic Malignancies Research Program STADTMAUER, EDWARD UNIVERSITY OF PENNSYLVANIA PA $155,630
Lymphoma 2018 NCI 5R01CA221521-02 NFAT activation in kGPCR tumorigenesis FENG, PINGHUI UNIVERSITY OF SOUTHERN CALIFORNIA CA $377,438
Lymphoma 2018 NCI 5R35CA197353-03 Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host LEVY, RONALD STANFORD UNIVERSITY CA $894,960
Lymphoma 2018 NCI 5R01CA219960-02 PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma LIN, YI MAYO CLINIC ROCHESTER MN $180,184
Lymphoma 2018 NCI 3R01CA203923-02S1 IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis TARAKANOVA, VERA MEDICAL COLLEGE OF WISCONSIN WI $58,868
Lymphoma 2018 NIAID 5R01AI045073-20 Chemokines and Lymphoid Tissue Organization and Function CYSTER, JASON UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $356,625
Lymphoma 2018 NCI 5F31CA220985-02 Investigating Bruton's Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma TANG, SARAH SLOAN-KETTERING INST CAN RESEARCH NY $44,524
Lymphoma 2018 NCI 5U54CA190152-05 7396 Project 1 GOPAL, SATISH UNIV OF NORTH CAROLINA CHAPEL HILL NC $55,260
Lymphoma 2018 NCI 5U54CA190152-05 7397 Project 2 GOPAL, SATISH UNIV OF NORTH CAROLINA CHAPEL HILL NC $219,613
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer